Iovance Biotherapeutics (NasdaqGM:IOVA) reported real-world clinical results for Amtagvi (lifileucel) in advanced melanoma, indicating a best-in-class efficacy profile. The company shared these data ...

Merck (NYSE:MRK) has received Health Canada approval for ENFLONSIA (clesrovimab), a monoclonal antibody for RSV prevention in newborns and infants. The product is indicated for the prevention of lower ...

Roivant Sciences (ROIV) upgraded to Buy on strong Phase 2 BEACON data for brepocitinib; see pipeline upside, risks, and why ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

Prosper Junior Bakiny has positions in Intuitive Surgical and Vertex Pharmaceuticals. The Motley Fool has positions in and ...

Will this biotech's innovative platform finally pay off?

Credence Research Inc. announces the publication of its latest report on the Global Retail Pharmacy Market, which is projected to grow from USD 1,445.9 billion in 2024 to USD 1,965.9 billion by 2032, ...

Investors are turning their attention to Myriad Genetics as the company prepares to release its audited financial results for ...

On Thursday, Feb. 5, the University of Utah hosted the Higher Education Appropriations Subcommittee in the Health Science Building on campus.

Shin Nippon Biomedical Laboratories, Ltd. ( (JP:2395) ) has shared an announcement.

Detailed price information for Strata Critical Medical Inc (SRTA-Q) from The Globe and Mail including charting and trades.

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...